EHAMIA
UTHR icon

EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s United Therapeutics UTHR Stock Holding History

EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-614
Closed -$299K – 137
2025
Q4 		$299K Sell
614
-268
-30% -$125K 0.25% 111
2025
Q3 		$370K Sell
882
-297
-25% -$99.9K 0.32% 95
2025
Q2 		$339K Sell
1,179
-36
-3% -$10.8K 0.33% 96
2025
Q1 		$375K Sell
1,215
-144
-11% -$49.3K 0.38% 85
2024
Q4 		$480K Sell
1,359
-16
-1% -$5.88K 0.48% 70
2024
Q3 		$493K Sell
1,375
-107
-7% -$36.1K 0.49% 69
2024
Q2 		$472K Sell
1,482
-35
-2% -$9.26K 0.5% 64
2024
Q1 		$348K Buy
+1,517
New +$342K 0.37% 88

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

EAGLE HARBOR ASSET MANAGEMENT INC /ADV's UTHR Position: Q1 2026 in Review

EAGLE HARBOR ASSET MANAGEMENT INC /ADV sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 614 shares — an estimated $299K sold.

EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in UTHR in Q1 2024 and held it in 8 quarters. The position peaked at $493K in Q3 2024. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV sold 614 United Therapeutics shares in Q1 2026, an estimated $299K.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in United Therapeutics in Q1 2024 and held it in 8 quarters.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV's United Therapeutics position peaked at $493K in Q3 2024.
  • 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on EAGLE HARBOR ASSET MANAGEMENT INC /ADV's 13F filing for Q1 2026, filed 11 Aug 2026.